| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |